Cerecor

spiral stairs downward end dark black
Biotech

Avalo spirals amid default, spurring attempt to sell assets

After working through a default with its creditors in July, troubled Avalo Therapeutics is looking to sell or license its core assets.
Annalee Armstrong Aug 3, 2023 10:45am
Apollo moon landing astronaut space

Apollo lands inflammatory antibody from Avalo for $90M biobucks

Aug 1, 2022 10:36am
Businessperson walking out

Avalo adjusts almost entire pipeline weeks after CEO, CFO depart

Mar 2, 2022 2:43pm
COVID-19 vaccine

Little Cerecor sees shares jump on COVID-19 readout, seeks EUA

Mar 2, 2021 9:20am
Parachute

Aurinia poaches CEO Peter Greenleaf from Cerecor

Apr 12, 2019 10:49am
Duke University

Duke startup Evecxia brings on ex-Cerecor chief as CEO

Aug 16, 2018 10:20am